CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
Received 10 May 2019
Accepted for publication 2 September 2019
Published 16 September 2019 Volume 2019:14 Pages 7549—7560
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Mian Wang
Zhan Su,1,2 Duanqin Liu,1,2 Liying Chen,2 Jun Zhang,1,2 Lu Ru,2 Zhiyu Chen,2 Zhennan Gao,1,2,* Xuxia Wang1,2,*
1Shandong Provincial Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Jinan, Shandong 250012, People’s Republic of China; 2Department of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, Jinan, Shandong 250012, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhennan Gao;Xuxia Wang
Department of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, 44-1 West Wenhua Road, Jinan, Shandong 250012, People’s Republic of China
Tel +86 531 15169070891
; +86 531 13906410670
Email [email protected]; [email protected]
Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignant tumor in the world. Studies in recent years have demonstrated that cancer stem cells (CSCs) are present in many tumor tissues, including HNSCC, and CSCs are the root cause of tumor recurrence and metastasis. Thus, taking new treatment measures to target the killing of CSCs that are resistant to chemotherapy and radiotherapy is key to the success of cancer treatment.
Methods: We explored a method for preparing anti-CD44 antibody-modified superparamagnetic iron oxide nanoparticles (SPIONPs). Biocompatibility was evaluated by a CCK-8 assay. The CSCs were obtained by a 3D cell culture technique from Cal-27 (human oral squamous cell carcinoma) cells, and then the CSCs were identified by quantitative real-time polymerase chain reaction (qRT-PCR). The targeting efficiency of the CD44-SPIONPs to CSCs was confirmed by Prussian blue staining and visualized by laser scanning confocal microscopy (LSCM). Flow cytometry was used to detect the apoptosis of CSCs after alternating magnetic field (AMF) treatment. The efficacy of tumor growth inhibition by CD44-SPIONP-mediated magnetic hyperthermia therapy was evaluated with tumor xenografts in nude mice.
Results: The CD44-SPIONPs exhibited no negative effect on CSCs, indicating good biocompatibility. After SPIONPs were cocultured with stem cells, the majority of CD44-SPIONPs labeled with FITC penetrated the cell membrane into the cytoplasm. After AMF treatment, CD44-SPIONPs induced CSCs to undergo programmed death. The inhibitory ratio of the treated group was 33.43%, and necrotic areas in the tumor tissue were mainly distributed around the magnetic fluid.
Conclusion: These results demonstrate that it is possible to kill CSCs using targeted magnetic nanoparticles and an AMF and that magnetic fluid hyperthermia significantly inhibited the growth of grafted Cal-27 tumors in mice.
Keywords: magnetic nanoparticles, cancer stem cells, alternating magnetic field, tumor targeting
Surgery, chemotherapy, and radiotherapy are still common methods for the treatment of HNSCC. However, the side effects of radiotherapy and chemotherapy seriously affect the quality of life and survival time of patients.1,2 Therefore, it is imperative to research and develop a more effective, safe, and minimally invasive or noninvasive HNSCC treatment method. Studies in recent years have demonstrated that CSCs are present in many tumor tissues, including HNSCC.3–5 CSCs are a group of cells within the whole population of cancerous cells that are capable of self-renewal and both sustain tumorigenesis and cause metastasis. Moreover, large numbers of CSCs accumulate in tumor tissues after chemotherapy and radiotherapy.6,7 Developing new therapeutic measures that kill CSCs that are resistant to chemotherapy and radiotherapy is the key to the success of cancer treatment.
Traditional tumor hyperthermia has played an important role in the treatment of cancer, but these traditional thermotherapy techniques cannot effectively kill CSCs.8 Although nanoparticle-mediated laser hyperthermia can kill CSCs, laser hyperthermia is generally suitable for the treatment of only superficial tumors.9
The principle of magnetic fluid hyperthermia is to use magnetic nanoparticles under an alternating magnetic field (AMF) to generate heat through magnetic vector rotation and physical rotation. Magnetic fluid containing magnetic nanoparticles can be administered through a tumor-feeding artery or by direct injection.10 After reaching the inside of the cells by endocytosis, under the external AMF, a high-temperature zone is quickly formed inside the tumor to achieve the effect of killing tumor cells or inducing apoptosis while preventing the normal surrounding tissues from being heated.
Sadhukha’s research demonstrated that SPIONP-mediated hyperthermia therapy can kill CSCs.11 However, there is currently no study of targeted magnetic fluid hyperthermia for CSCs. With in-depth study, some characteristic surface marker proteins of CSCs have been verified. The discovery of these surface markers enables the enrichment, identification, and targeting of CSCs.12,13 CD44 is a cell-surface glycoprotein that plays a role in cell adhesion and migration, serves as a receptor for hyaluronic acid and interacts with other ligands, such as osteopontin, collagen, and matrix metalloproteinases.14,15 CD44 participates in a wide variety of cellular functions, such as lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis.16,17 Herein, we demonstrate the possibility of targeting CD44-overexpressing CSCs with CD44-SPIONPs and applying magnetic fluid hyperthermia.
Materials And Methods
Reagents And Instrumentations
Fetal bovine serum (FBS), Dulbecco’s Modified Eagle’s medium (DMEM), Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F-12 (DME/F12) and phosphate buffer saline (PBS) were purchased from Hyclone (LA, USA). Trypsin-EDTA solution was purchased from Merck KGaA (Darmstadt, Germany). 4-Morpholineethanesulfonic acid hydrate (MES), 1-(3-dimethylaminopropyl)-3-ethyl carbodiimide hydrochloride (EDC) were purchased from Aladdin (Shanghai, China). Mouse Anti Human CD44 FITC (sc-7297) was purchased from Santa Cruz Biotechnology (CA, USA). BCA Protein Assay Kit was purchased from Thermo Fisher Scientific (MA, USA). Epidermal growth factor (EGF) peptide and basic fibroblast growth factor (bFGF) were purchased from PeproTech (NJ, USA). B-27 supplement was purchased from Gibco (CA, USA). Ultra-low attachment multiwell plate was purchased from Corning (NY, USA). Cell Counting Kit-8 (CCK8) was purchased from DOJINDO (Tokyo, Japan). Trizol was purchased from Thermo Fisher Scientific (MA, USA). First strand cDNA Synthesis Kit and SYBR Green I was purchased from Takara Biomedical Technology (Beijing, China). Zetasizer Nano ZSE was purchased from Malvern Panalytical (Malvern, UK).
Cell Lines And Animals
Cal-27 cells were purchased from the Laboratory Animal Center of Shandong University (Jinan, China). Cells were cultured using DMEM containing 10% FBS and 1% of penicillin, and maintained in a controlled atmosphere at 37°C, 95% relative humidity, and 5% CO2. The culture medium was changed every three days. The use of cell lines was approved by Ethics Committee of Stomatological Hospital of Shandong University.
Male BALB/c nude mice (4−5 weeks old, about 20g) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing, China). The use and management of animals was legally acquired and conducted in compliance with the protocol approved by the Ethics Committee of Stomatological Hospital of Shandong University. The maintenance of all the experimental animals that were used in this study was performed according to guidelines of the Institutional Animal Care and Use Committee of Shandong University.
Preparation Of CD44-SPIONPs
SPIONPs were synthesized by the coprecipitation method, which involves the simultaneous precipitation of Fe2＋ and Fe3＋ ions in basic aqueous media. Briefly, 10 mL of 0.05 mol/L FeCl2, 10 mL of 0.1 mol/L FeCl3 and 50 mL of 5 g/L carboxymethyldextran (CMDx) solution were stirred at 150 rpm at 80°C for 1 h while adjusting the pH to 9–10 by adding NH3H2O. Meanwhile, deionized water was added to compensate for evaporation. Subsequently, the nanoparticles were washed three times with ethanol (1:3) at 3,500 rpm for 20 min and dried at room temperature. Carboxymethyldextran-modified magnetic nanoparticles were powdered and kept at 4°C.18,19
Next, 10 mg of sterilized CMDx-coated nanoparticles were suspended in 0.5 mL of MES buffer (1 g of MES in 10 mL of deionized water) by ultrasonication for 5 min, and the solution was adjusted to pH 6. Then, 0.5 mL of EDC solution (10 mg of EDC in 1 mL of Activation Buffer containing 0.1 M MES and 0.5 M NaCl, pH=6.0) was added, and the reaction was allowed to proceed for 40 min at room temperature. Then, 200 μl of 200 μg/mL mouse anti-human CD44 FITC was added and incubated for 18 h at room temperature in a shaker at 200 rpm while avoiding light. The suspension was centrifuged at 5,000 rpm for 30 min to obtain the nanoparticles. The CD44 conjugation reaction was reproducible (3.82±0.69 μg/mg), as determined by a BCA protein assay.
Characterization Of Nanoparticles
The crystalline phase of the SPIONPs was characterized by X-ray diffraction (XRD) measurements. The static magnetic properties of dry SPIONPs and CD44-SPIONPs at room temperature were measured with a vibrating sample magnetometer. The size distribution and morphology of the CD44-SPIONPs were characterized by transmission electron microscopy (TEM). Dynamic light scattering (DLS) curves of the size distribution were obtained using a Nano Sizer.
Meanwhile, the CD44-SPIONPs (0 μg, 250 μg, 500 μg, 750 μg, and 1 mg) were weighed, and 5 mL of physiological saline was added to form a magnetic fluid at room temperature. Under a frequency of 273 kHz and an output current of 50 A, the AMF was applied for 30 min, with a fiber-optic temperature sensor to measure and record the temperature and draw the corresponding graph.
3D Spheroid Culture
To obtain tumorspheres, Cal-27 cells were seeded at 1X104 cells/mL in DMEM/F12 supplemented with 20 ng/mL bFGF, 20 ng/mL EGF, 5 μg/mL insulin, and 0.02x B-27 supplement in each well of an ultralow attachment multiwell plate in approximately 4 mL. A 1/3 volume of fresh culture medium was added every 3–4 days, and the cells were cultured for approximately 7–10 days. Then, the cells congregated into tumorspheres.
To obtain CSCs, the spheres were allowed to settle by gravity sedimentation for 10 min, and then the supernatant was aspirated. Then, 1 mL of Trypsin-EDTA solution was added to the tumorspheres, and the spheres were pipetted up and down 10–20 times to generate a single cell suspension. The cells were centrifuged for 5 min at 300 x g. The supernatant was discarded, and the cells were seeded at 105 cells/mL in six-well dishes for further experiments.22,23
Quantitative Real-Time PCR Analysis
Total RNA was isolated from Cal-27 cells and CSCs using TRIzol reagent and then reverse transcribed with a reverse transcription kit according to the manufacturer’s protocol. The qRT-PCR primers were used to detect the gene expression of Oct4, Sox2, and Nanog, with Gapdh as the reference. The following primer sequences were used: for Oct4, 5′-TCAGGAGATATGCAAAGCAGAAAC-3′ (forward) and 5′-CTGATCTGCTGCAGTGTGGG -3′ (reverse); for Sox2, 5′-GACAGTTACGCGCACATGAA -3′ (forward) and 5′-TAGGTCTGCGAGCTGGTCAT -3′ (reverse); for Nanog, 5′- AGGGTCTGCTACTGAGATGCTCTG -3′ (forward) and 5′- CAACCACTGGTTTTTCTGCCACCG -3′ (reverse); and for Gapdh, 5′- GCACCGTCAAGGCTGAGAAC -3′ (forward) and 5′- TGGTGAAGACGCCAGTGGA -3′ (reverse).24
Western Blot Analysis
Cal-27 cells and CSCs were collected and incubated with RIPA buffer. The cell lysate was centrifuged at 12,000 rpm at 4°C for 10 min. The supernatant was boiled after adding 5x SDS sample buffer. Proteins were separated using 10% sodium dodecyl sulfate‑polyacrylamide gel electrophoresis for 1.5 h at 100 V and transferred onto polyvinylidene fluoride membranes. After blocking with 5% nonfat milk, the membranes were probed overnight at 4°C with primary antibodies, which were rabbit anti-CD44 (1:5,000, Abcam, ab51037) and rabbit anti-Gapdh (1:10,000, Abcam, ab181602). The membrane was washed and then incubated with HRP-conjugated secondary goat anti-rabbit antibodies (1:10,000, Abcam, ab6721) for 1 h at room temperature. Target proteins were detected with enhanced chemiluminescence reagents and photographed.
In Vitro Cytotoxicity Study
The cytotoxicity of CD44-SPIONPs was evaluated using a CCK8 assay. The CD44-SPIONPs were sterilized for 24 h with UV light and then diluted in DMEM before incubation. A total of 5×104 cells obtained from spheres were plated into 96-well plates and incubated at 37°C overnight. Subsequently, the culture medium in each well was replaced with medium that contained CD44-SPIONPs at a series of concentrations and incubated for 24 h and 48 h. Then, 10 μl of CCK8 solution was added to each plate for 2 h. The absorbance was measured at 450 nm using a microplate reader.
Cellular Internalization Of CD44-SPIONPs
Loading of CD44-SPIONPs into CSCs was confirmed by Prussian blue staining. Briefly, CSCs were seeded in 24-well plates and cultured with DMEM containing CD44-SPIONPs at a concentration of 100 µg/mL for 24 h; wells without CD44-SPIONPs were included as the control group. After incubation, the cells were washed three times with PBS. Following fixation for 20 min in 4% paraformaldehyde at room temperature, the cells were incubated in a Prussian blue staining solution (1:1 mixture of 1 mol/l hydrochloric acid and potassium ferrocyanide) for 30 min at room temperature. Each well was washed with PBS and analyzed by light microscopy.
For localization measurements, CD44-SPIONPs tagged with FITC were cultured with Cal-27 cells and CSCs, which were seeded on confocal laser dishes at a density of 5×104 cells per dish for 24 h at a concentration of 100 μg/mL. After incubation, the cells were washed three times with warm PBS and stained using a 5 μg/mL DAPI solution for 15 min at 37°C to stain the cell nucleus. A Carl Zeiss LSM 780 confocal laser scanning microscope was used to visualize nanoparticle interactions with cells.25,26
To investigate the destructiveness of CD44-SPIONPs to CSCs after AMF treatment, the CSCs were seeded in six-well culture plates at a density of 1×105 cells per well and then incubated with CD44-SPIONPs at a concentration of 100 μg/mL for 24 h. After being washed three times with PBS to remove the free CD44-SPIONPs, the cells were exposed to AMF treatment. The magnetic field was applied for a period of 2 h at 237 kHz and 50 A. The temperature was monitored using a fiber-optic temperature sensor and maintained between 43°C and 45°C. The three control groups were as follows: ① cells without CD44-SPIONPs and AMF treatment, as the blank control group; ② cells without CD44-SPIONPs and with AMF treatment; and ③ cells with CD44-SPIONPs and without AMF treatment.
Flow Cytometry Analysis
After incubation for an additional 24 h in an incubator, the cells were collected at a concentration of 1×106 cell/mL and washed with cold PBS three times. Then, the cells were stained with 5 μl of Annexin V-FITC and 5 μL of PI for 15 min at room temperature in the dark. The cells were analyzed with a flow cytometer (BD Accuri C6 Plus personal flow cytometer, BD, USA). The data were examined using the BD Accuri C6 Plus software (BD, USA). Cells incubated with normal growth medium without AMF treatment were used as control groups.
In Vivo Hyperthermia Therapy
To prepare the tumor model, 5×107/0.1 mL of Cal-27 cells were subcutaneously injected into the right flanks of the mice. After four days, the mice were randomly divided into four groups with five mice in each group. The tumor volume was calculated using the formula V = 1/2ab,2 where “a” represents the major diameter of the tumor (mm) and “b” represents the minor diameter perpendicular to the major diameter (mm).
The mice were anesthetized with chloral hydrate before treatment. The treatment group was injected at four different points within the tumor with 0.2 mL of CD44-SPIONPs (100 μg/mL). The mice were subsequently exposed to an AMF with a maximum magnetic intensity of 237 kHz and 50 A for 30 min (as Group D). The three control groups were intratumorally injected ① with 0.2 mL of physiological saline (as Group A), ② with 0.2 mL of CD44-SPIONPs (100 μg/mL) (as Group B), and ③ with 0.2 mL of physiological saline and exposure to the same AMF (as Group C). Two mice were chosen randomly from each group to detect the real-time intratumoral temperature and rectal temperature by fiber-optic detection.
Two mice were randomly chosen from each group and sacrificed 24 h after hyperthermia. The tumors were immediately removed and dissected. The resected tumors were fixed in 10% formalin, embedded in paraffin, sectioned and stained with hematoxylin-eosin. The tumors were then histologically observed.
Other mice were sacrificed after two weeks. The tumor volume was measured to calculate the ratio of inhibition. The Tumor Growth Inhibition value (TGI) = (1-tumor volume of treatment group/tumor volume of control group) *100%.
All statistical analyses were performed using GraphPad Prism 6 (GraphPad Software Inc., San Diego CA). The sample number for each group was ≥3, and numerical data were reported as the mean ± SD. P values were considered to be statistically significant at p<0.05.
Synthesis And Characterization Of CD44-SPIONPs
XRD patterns of SPIONPs were matched with bulk Fe3O4 (JCPDS #: 19–0629), revealing their spinel crystal structure. The magnetic saturation intensity results of SPIONPs and CD44-SPIONPs are shown in Figure 1A. At room temperature, the magnetic saturation strengths of SPIONPs and CD44-SPIONPs were 57 emu/g Fe and 23 emu/g Fe, respectively. In addition, the hysteresis curve passes through the origin, as illustrated in Figure 1B, indicating that when the applied magnetic field is zero, the magnetic saturation intensity of both SPIONPs and CD44-SPIONPs is zero, which means that the hysteresis is zero.
Observation by TEM (Figure 1C) of the CD44-SPIONPs thus obtained demonstrated a spherical structure with an average diameter of approximately 100 nm. The DLS distribution (Figure 1D) showed a narrow peak centered at approximately 150 nm in diameter.
From the temperature-time curve, it can be seen that in the first 25 min, the CD44-SPIONPs slowly increase the temperature under the AMF, after which the temperature remains in a stable range. As shown in Figure 1E, 200 μg/mL CD44-SPIONPs reached a maximum of 64.5°C, 150 μg/mL CD44-SPIONPs reached a maximum temperature of approximately 58.1°C, 100 μg/mL CD44-SPIONPs reached a maximum temperature of 50°C, and 50 μg/mL CD44-SPIONPs reached a maximum of 43.6°C; for the 0 μg/mL concentration, the temperature did not rise.
Characterization Of CSCs
On the second day of culture, a small number of microspheres could be observed. From 4 to 5 days, we observed golf ball-like spheres ranging from 300 to 500 cells per sphere. The middle region was dense due to the large number of cells, and the transmittance was poor. By 7 to 10 days, the cell spheres were irregular in shape. They could be collected for detection or subculture (Figure 2).
Figure 2 Sphere formation. Representative phase-contrast micrographs of spheres formed by Cal-27 cell lines. Bar: 100 μm.
Stem cell markers such as Oct4, Sox2, and Nanog are known to form a self-organized core of transcription factors that maintain the pluripotency and self-renewal of human embryonic stem cells. We found that the gene expression of Oct4, Sox2, and Nanog was significantly increased in CSCs compared with that in Cal-27 cells, as observed in Figure 3A.
Western blotting analysis of Cal-27 and CSCs proteins showed that both Cal-27 cells and CSCs have CD44 expression. By gray-scale analysis of protein bands, the expression level of CD44 in CSCs was significantly higher than that in Cal-27 cells (p<0.05), as observed in Figure 3B.
The cytotoxicity of CD44-SPIONPs was evaluated using a CCK8 assay. The cell viability results after 24 h and 48 h are shown in Figure 3C. In the range of 0–100 μg/mL, there was no significant difference in the survival rate (p>0.05), indicating that CD44-SPIONPs exhibited no negative effect on the growth and proliferation of the CSCs.
Cellular Uptake Of CD44-SPIONPs
Intracellular “Fe” was detected by Prussian blue staining of CSCs. After incubation with the CD44-SPIONPs, the labeled cells displayed a typical blue color, whereas unlabeled cells did not exhibit blue staining (as shown in Figure 4A).
The uptake and targeting ability of CD44-SPIONPs were investigated in the CSCs, and Cal-27 cells were used as a control group. The subcellular location of CD44-SPIONPs labeled with FITC was studied by utilizing a laser scanning confocal microscope. The CSCs were stained with DAPI to visualize the nucleus so that we could observe the relationship between cells and SPIONPs. The majority of CD44-SPIONPs labeled with FITC penetrated the cell membrane into the cytoplasm. In contrast, few CD44-SPIONPs were observed distributed in the cytoplasm of Cal-27 cells, as shown in Figure 4B. These results proved that a large number of CD44-SPIONPs were efficiently internalized by CSCs.
Apoptosis Determination By Annexin V-FITC/PI Staining
Cell apoptosis was studied by Annexin V-FITC/PI staining and quantified by flow cytometry. For the cells with nanoparticles, compared to the AMF- group, CD44-SPIONPs induced programmed cell death under AMF. The quantitative results of flow cytometry are shown in Figure 5. After AMF treatment, 44.5% of cells underwent early apoptosis, and 4.7% were late apoptotic cells. The apoptotic ratio of the AMF- group was 10% and 1.5%, respectively. The difference was statistically significant (p﹤0.05). For the cells without nanoparticles, the quantitative results of the AMF+ group were similar to those of the blank control group (p>0.05). These results indicated that the CD44-SPIONPs could significantly induce apoptosis in CSCs after AMF treatment.
In Vivo Study
During hyperthermia, the intratumoral temperature of Group D increased to 43°C in 10 min and fluctuated around 43°C under an AMF (Figure 6A). The rectal temperature of groups A to D remained steady at approximately 36.5°C (Figure 6B).
The tumor volume of the treatment group was smaller than that of the three control groups; the ratios of inhibition were all above 33% (P<0.05). The tumor volumes of the grafted tumors are shown in Table 1.
Table 1 The Tumor Growth Inhibition Value Of Cancer In Nude Mice Following Treatment
Following hyperthermia, in Group D, a large number of apoptotic tumor cells with the characteristics of karyopyknosis and condensation were discovered. Acidophilia increased, and the normal cell structure disappeared. Hemorrhagic lesions were detected in certain apoptotic and necrotic areas. The magnetic fluid was distributed between the apoptotic and necrotic areas.
In the control groups, the nucleoli were stained, and karyokinesis was occasionally detected. There were a few ischemic necrotic tissues observed in the center, and scattered nanoparticles were observed between the tumor tissues in Group B, as shown in Figure 6C.
Compared with other treatment methods, tumor thermotherapy has the following characteristics. First, in vivo and in vitro studies have confirmed that tumor cells are more sensitive to heat than normal cells, especially in the center of the tumor, which is in a state of low nutrition and hypoxia. Second, the blood vessels in the tumor have no innervation; thus, the resistance of blood flow in tumor tissue is large, resulting in a slow blood flow speed. Thus, the effectiveness of blood circulation is far lower than that of normal tissue, which makes the tumor more likely to accumulate heat and more susceptible to temperature. When heated, the temperature of the tumor area is 3-7°C higher than that of the surrounding normal tissues.27,28 Therefore, at the time of treatment, the central part of the tumor can be heated to above 43°C to induce degeneration and necrosis of the cells, and damage to normal tissues surrounding the tumor can be avoided. Moreover, thermotherapy can also inhibit the synthesis of DNA and RNA in tumor cells and can cause denaturation of essential proteins for cell proliferation, thereby inhibiting the proliferation process of tumor cells and increasing the lethality of the treatment for tumor cells.29
Many cell lines were derived from cancer stem-like cells, which were isolated in standard culture media without epidermal growth factor or a fibroblast feeder layer to avoid obtaining clones of more differentiated cells.30 However, in the later cultivation process, cells will inevitably differentiate, resulting in the heterogeneity of tumor cell lines. Some cells with self-renewal capacity become stem cell-like cells, which can be separated from normal cells by 3D spheroid culture.31–33 Cancer cells require higher serum levels and are adherent in culture medium, while CSCs are highly dependent on growth factors. Suspension culture is carried out in serum-free medium containing epidermal growth factors, in which only stem cells with self-renewal ability can proliferate and form cell spheres, while non-stem cells gradually undergo necrosis. At present, 3D spheroid culture technology has become a common method for studying CSCs.23
Superparamagnetic Fe4O3 particles are magnetic nanomaterials with broad application prospects in biomedical fields. The preparation method is relatively simple, and the raw materials are easy to obtain. In our experiment, Fe4O3 particles were obtained by coprecipitation and reacted with carboxymethyl dextran to obtain a carboxyl terminal (-COOH), and an amide bond (-CO-NH-) was covalently coupled with the amino terminus (-NH2) of the CD44 antibody. Biosafety evaluation of the CD44-SPIONPs showed good biocompatibility.
In recent years, some studies have confirmed that CD44-positive cells account for less than 10% of all head and neck tumor cells, but these cells have a strong ability to clone and self-renew, as well as the ability to initiate tumors.15 CD44 on the surface of many cells is in a relatively static state, while CD44 on the surface of CSCs is in an overexpression state, which can bind to its ligand, leading to the immune escape of cancer cells, and can promote the occurrence, development, invasion and metastasis of tumors.17,34 Western blot results showed that CSCs overexpressed CD44 compared to Cal-27 cells. Therefore, we selected the CD44 antibody receptor on the surface of CSCs as a target and labeled the CD44 antibody with FITC fluorescence. After coculture with cells, it was observed by confocal microscopy that CD44-SPIONPs penetrated into the cytoplasm through the cell membrane.
Furthermore, the in vivo results in this study also prove that magnetic fluid hyperthermia can inhibit the growth of grafted tumors in mice. These results are important in light of the clinical use of CD44-SPIONP-mediated hyperthermia therapy for head and neck squamous cell carcinoma.
Our experiments confirmed that it is possible to kill CSCs using targeted magnetic nanoparticles and an AMF. We have demonstrated that nanoparticles can penetrate the cell membrane, enter the interior of the cells, and significantly reduce cell viability by heating in a magnetic field, leading to programmed cell death. Magnetic fluid hyperthermia is able to significantly inhibit grafted tumor growth in the Cal-27 mouse model. These observations offer a promising strategy for using targeted magnetic nanoparticles to treat cancers and reduce metastasis. However, more studies are needed to optimize the regimens in further applications.
This research was supported by the Shandong Province Science and Technology Development Project (2015GSF118151).
The authors report no conflicts of interest in this work.
1. Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2012;13(2):163–171. doi:10.1016/S1470-2045(11)70320-5
2. Chua DT, Sham JS, Au GK, Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis. Int J Radiat Oncol Biol Phys. 2002;53(2):334–343. doi:10.1016/s0360-3016(02)02710-4
3. Krishnamurthy S, Nör JE. Head and neck cancer stem cells. J Dent Res. 2012;91(4):334–340. doi:10.1177/0022034511423393
4. Sayed SI, Dwivedi RC, Katna R, et al. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol. 2011;47(4):237–243. doi:10.1016/j.oraloncology.2011.02.009
5. Krishnamurthy S, Dong Z, Vodopyanov D, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010;70(23):9969–9978. doi:10.1158/0008-5472.CAN-10-1712
6. Zhao Y, Bao Q, Schwarz B, et al. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases. Stem Cells Dev. 2014;23(2):180–192. doi:10.1089/scd.2013.0103
7. Fang DD, Cao J, Jani JP, et al. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line. Front Med-Prc. 2013;7(4):462–476. doi:10.1007/s11684-013-0270-6
8. Campos MS, Neiva KG, Meyers KA, Krishnamurthy S, Nör JE. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol. 2012;48(1):26–32. doi:10.1016/j.oraloncology.2011.09.010
9. Burke AR, Singh RN, Carroll DL, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012;33(10):2961–2970. doi:10.1016/j.biomaterials.2011.12.052
10. Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotechnol J. 2011;6(11):1342–1347. doi:10.1002/biot.201100045
11. Sadhukha T, Niu L, Wiedmann TS, Panyam J. Effective elimination of cancer stem cells by magnetic hyperthermia. Mol Pharmaceut. 2013;10(4):1432–1441. doi:10.1021/mp400015b
12. Kaseb HO, Fohrer-Ting H, Lewis DW, Lagasse E, Gollin SM. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Exp Cell Res. 2016;348(1):75–86. doi:10.1016/j.yexcr.2016.09.003
13. Bourguignon LYW, Earle C, Shiina M. Activation of matrix hyaluronan-mediated CD44 signaling, epigenetic regulation and chemoresistance in head and neck cancer stem cells. Int J Mol Sci. 2017;18(9):1849. doi:10.3390/ijms18091849
14. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030–1037. doi:10.1158/0008-5472.CAN-06-2030
15. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973–978. doi:10.1073/pnas.0610117104
16. Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol. 2000;32(1):78–84. doi:10.1016/s0168-8278(00)80192-0
17. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009;45(7):633–639. doi:10.1016/j.oraloncology.2008.10.003
18. Creixell M, Bohórquez AC, Torres-Lugo M, Rinaldi C. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano. 2011;5(9):7124–7129. doi:10.1021/nn201822b
19. Shen Y, Wu C, Uyeda TQP, et al. Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field. Theranostics. 2017;7(6):1735–1748. doi:10.7150/thno.18352
20. Shevtsov MA, Nikolaev BP, Yakovleva LY, et al. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomedicine. 2014;9:273–287. doi:10.2147/IJN.S55118
21. Zhu LL, Zhang Z, Jiang HS, Chen H, Chen Y, Dai YT. Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction. Asian J Androl. 2017;19(4):425–432. doi:10.4103/1008-682X.179532
22. Lim YC, Oh S, Cha YY, Kim S, Jin X, Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol. 2011;47(2):83–91. doi:10.1016/j.oraloncology.2010.11.011
23. Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. 2012;323(2):161–170. doi:10.1016/j.canlet.2012.04.004
24. Fu T, Hsieh I, Cheng J, et al. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med. 2016;45(2):89–95. doi:10.1111/jop.12335
25. Guo X, Li W, Luo L, et al. External magnetic field-enhanced chemo-photothermal combination tumor therapy via iron oxide nanoparticles. Acs Appl Mater Inter. 2017;9(19):16581–16593. doi:10.1021/acsami.6b16513
26. Creixell M, Herrera AP, Ayala V, et al. Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells. J Magn Magn Mater. 2010;322(15):2244–2250. doi:10.1016/j.jmmm.2010.02.019
27. Kruse AM, Meenach SA, Anderson KW, Hilt JZ. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater. 2014;10(6):2622–2629. doi:10.1016/j.actbio.2014.01.025
28. Chen Q, Ke H, Dai Z, Liu Z. Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials. 2015;73:214–230. doi:10.1016/j.biomaterials.2015.09.018
29. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497.
30. Gioanni J, Fischel JL, Lambert JC, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol. 1988;24(9):1445–1455.
31. Akbarzadeh M, Maroufi NF, Tazehkand AP, et al. Current approaches in identification and isolation of cancer stem cells. J Cell Physiol. 2019;234(9):14759–14772. doi:10.1002/jcp.28271
32. Shrivastava S, Steele R, Sowadski M, Crawford SE, Varvares M, Ray RB. Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep-Uk. 2015;5(1).
33. Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004;3(4):414–415. doi:10.4161/cc.3.4.799
34. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009;277(2):227–234. doi:10.1016/j.canlet.2008.12.015
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]